Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite
NCT ID: NCT05949502
Last Updated: 2023-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
26 participants
INTERVENTIONAL
2023-08-31
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Low-shrinkage Giomer Versus Resin-Modified Glass Ionomer in Cervical Caries Lesions: A Clinical Trial
NCT05930548
Partial Caries Removal in Permanent Molars Restored Using Giomer
NCT06601972
Performance of GIOMER Based Resin Composite
NCT06021028
Clinical Performance and Wear Resistance of Highly Translucent Nano Zirconia Reinforced Glass Ionomer Filling Versus Conventional Resin Composite Restorations in Patients With Proximal Carious Teeth. (A One-year Randomized Clinical Trial).
NCT05403008
18-Month Clinical Evaluation of Self-Adhesive Flowable Giomer Compared to Conventional Flowable Giomer in Conservative Occlusal Restorations
NCT06956651
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Two different restorative materials will be evaluated after two years for fracture, retention and occlusal wear. Furthermore, the rest of the revised FDI Criteria including functional (marginal adaptation, proximal contact point, form and contour, occlusion and occlusal wear) , biological (caries at restoration margin (CAR), dental hard tissue defects at restoration margin and postoperative hypersensitivity/pulp status) and esthetic properties (surface luster and surface texture, marginal staining and color match) will be also evaluated.
The first material is based on the giomer technology which is a true hybrid between nano-hybrid resin composite and glass ionomer. The comparator will be a nano-hybrid resin composite.
Examination and selection of all patients will be done. Teeth with proximal, primary carious lesions will be selected. Rubber dam isolation will be done followed by preparation of Class II cavities and placement of restorative material according to the randomization sequence.
Low-shrinkage bioactive material will be applied according to the manufacturer's instructions. For the comparator group, nano-hybrid resin composite will be also applied according to the manufacturer's instructions. Restorations will evaluated at baseline, after six, 12, 18 and 24 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low shrinkage giomer.
Low-shrinkage bioactive material (giomer) will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. This will be followed by light curing of each increment for 40 seconds using light curing unit till the whole cavity is filled.
Beautifil II LS (Low-Shrinkage)
low shrinkage bioactive material Giomer
Nano-hybrid resin composite
Nano-hybrid resin composite will be applied according to the manufacturer's instructions. Centripetal technique will be performed to restore the proximal wall followed by oblique incrementation of approximately 2 mm thick composite resin. Composite increments will be adapted obliquely on each cusp. This will be followed by light curing for 40 seconds using light curing unit of each increment till the whole cavity is filled.
3M Filtek Z250 XT Universal
Universal Nano-hybrid composite
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Beautifil II LS (Low-Shrinkage)
low shrinkage bioactive material Giomer
3M Filtek Z250 XT Universal
Universal Nano-hybrid composite
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good oral hygiene.
* Patients who have stable occlusion.
* Patients who could be present for further periodic follow-ups.
* Possibility for application of rubber dam during restoration.
* Patient compliance.
* Vital first and second molars, with compound Class II lesions.
* The selected teeth should be in occlusion with natural dentition and having proximal contact with adjacent teeth.
* Healthy periodontium.
Exclusion Criteria
* Patients with high caries index or high plaque index.
* Patients with periodontal problems.
* Heavy bruxism habit or presence of any parafunctional habits.
* Any allergic reactions against any components of the materials to be used in the study.
* History of severe medical complications such as xerostomia.
* Pregnant or lactating women.
* Participating in another clinical trial.
* Fractured or evidently cracked teeth.
* Defective restorations adjacent or opposite the selected tooth for research.
* Atypical extrinsic staining of teeth.
* Teeth with defects or lesions requiring other operative interventions.
* Teeth with pulpal pain.
* Teeth with periapical lesions.
* Root Canal treated teeth.
* Mobile Teeth.
* Non-functioning teeth with no opposing tooth.
* Signs of severe attrition.
* Heavy occlusion.
* Periodontally affected teeth.
19 Years
30 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Omar Osama Shaalan
Lecturer
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Low shrinkage giomer
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.